GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (OTCPK:PSYGF) » Definitions » Research & Development

PSYGF (Psyence Group) Research & Development : $0.60 Mil (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Psyence Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Psyence Group's Research & Development for the three months ended in Dec. 2024 was $0.08 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $0.60 Mil.

Psyence Group Research & Development Historical Data

The historical data trend for Psyence Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group Research & Development Chart

Psyence Group Annual Data
Trend Dec19 Dec20 Mar22 Mar23 Mar24
Research & Development
- - 0.09 1.68 1.17

Psyence Group Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.25 - 0.27 0.08

Psyence Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Psyence Group  (OTCPK:PSYGF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Psyence Group Research & Development Related Terms

Thank you for viewing the detailed overview of Psyence Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (OTCPK:PSYGF) » Definitions » Research & Development
Comparable Companies
XCNQ:STRC.X TSXV:AQS TSXV:LFST TSXV:ENTG XCNQ:MGW XCNQ:SE XCNQ:PHRX XCNQ:STKT XCNQ:STPH XCNQ:OVAT LLY OCSE:NOVO B JNJ ABBV XSWX:ROG LSE:AZN MRK XSWX:NOVN AMGN PFE
Traded in Other Exchanges
PSYG:Canada
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1
Website
https://www.psyence.com
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.

Psyence Group Headlines

No Headlines